CHRI Applauds Introduction of Bipartisan "Horseracing Integrity Act of 2019"

Thursday, March 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, March 14, 2019 /PRNewswire/ -- The Coalition for Horse Racing Integrity (CHRI) today announced its strong support

for the Horseracing Integrity Act of 2019, introduced by U.S. Reps. Paul Tonko (D-NY) and Andy Barr (R-KY) earlier today.

The bill, designated as H.R. 1754, would create a private,

independent horse racing anti-doping authority, the Horseracing Anti-Doping and Medication Control Authority (HADA), responsible for developing and administering a nationwide anti-doping and medication control program for horse racing. HADA would be governed by a board composed of six individuals who have demonstrated expertise in a variety of horse-racing areas, six individuals from the United States Anti-Doping Agency, and its chief executive officer. USADA is recognized by Congress as the official anti-doping agency for the U.S. Olympic, Pan American, and Paralympic sports.

The new set of rules, testing procedures, and penalties would replace the current patchwork of regulatory systems that govern horse racing's 38 jurisdictions. Passage of this bill will result in a substantial increase in out-of-competition testing, which will help ensure horses are free from performance-enhancing drugs during racing and training.

"This is a horse-first bill. This bill will help ensure a safer environment for horses and riders at all tracks," said Shawn Smeallie, executive director of CHRI. "Representatives Tonko and Barr, along with their respective staff members, have worked tirelessly on this legislation. Thanks to their efforts, this initiative has gained the support of key stakeholders across the industry and continues to gain momentum. We look forward to working with other racing industry organizations to ensure productive legislative activity this year."

H.R. 1754 is nearly identical to the Horseracing Integrity Act of 2017 (H.R. 2651), also introduced by Reps. Barr and Tonko, which garnered the bipartisan support of more than 130 representatives last Congress. Joining the effort in 2019 are Rep. Jan Schakowsky (D-IL), chair of the House Energy and Commerce Subcommittee on Consumer Protection & Commerce, and Reps. Earl Blumenauer (D-OR) and Vern Buchanan (R-FL), co-chairs of the Congressional Animal Protection Caucus. CHRI is hopeful and optimistic that the legislation will move through the committee process this year, building on this strong showing of support from key lawmakers.

"Last year, I testified in front of Congress in support of this bill. Doping horses to boost their performance or to mask injuries forces unsound horses to race, which can result in breakdowns and deaths. The sport of horse racing needs national standards, more out-of-competition testing, and a ban on race-day medication," said Kitty Block, president and CEO of The Humane Society of the United States (HSUS). "HSUS is a proud member of the Coalition for Horseracing Integrity and will continue to work with its members for passage of this crucial equine protection bill."

"Horses should race and train only when they are free from performance-enhancing drugs and not on a cocktail of medications," said Marty Irby, executive director of Animal Wellness Action. "We are proud of the key leaders in the horse racing industry and animal protection groups that have come together on this bill."

The Coalition for Horse Racing Integrity represents a diverse group of racing organizations, racetracks, owner and breeder associations, and animal welfare groups that support adoption of a national, uniform standard for drug and medication rules in horse racing. For more information and to read a copy of the proposed legislation, visit horseracingintegrity.com.

Cision View original content:http://www.prnewswire.com/news-releases/chri-applauds-introduction-of-bipartisan-horseracing-integrity-act-of-2019-300812711.html

SOURCE The Coalition for Horse Racing Integrity



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store